UNLOCKING

CARDIOLOGY

IMMUNOLOGY

HEaLTHCARE

Life

We aim to create a lasting and meaningful impact on patients suffering from cardiac conditions.

Cardiovascular diseases are a major burden and the first cause of death globally.

18₊

Millions
deaths/year

85_%

caused by myocardial infarction
& stroke

300

millions Disability-adjusted
life years (DALY)

We unlock the potential of immunotherapies to reshape the future of Cardiovascular care.
The momentum around emerging Cardio-immunology field has never been stronger.

Our revolution

Patients

We aim to drastically reduce the burden of cardiovascular diseases by providing early-stage treatment to patients, thereby mitigating the damage inflicted to the heart.

Technology

We designed a first in class monoclonal antibody that specifically targets the immune system to prevent cardiac damage in ischemic cardiovascular diseases.

about POLYGON

Polygon emerges from cutting-edge academic research. The project is led by three co-founders with complementary backgrounds, all geared up to bring innovation from bench to patients' bed in a fresh, bold and committed approach.

NEWS

Our Latest news

Polygon at the J.P. Morgan Healthcare Conference Week 2025

January 13, 2025

Polygon at the CVCT Forum 2024 in Washington D.C.

December 9, 2024

Prof. Hafid Ait-Oufella recognized and honored by the French Academy of Sciences

November 26, 2024